US EditionKyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
- Amgen will present at the Jefferies Global Healthcare Conference on June 4, 2025, at 9:20 a.m. ET in Thousand Oaks, California.
- The presentation follows Amgen’s strategic efforts to communicate its innovation and commercial progress to investors and the public.
- Peter Griffith, EVP and CFO, and Murdo Gordon, EVP of Global Commercial Operations, will deliver the presentation and highlight company developments.
- The webcast will be streamed live online for media, investors, and the public, and will remain accessible for on-demand viewing for a minimum of three months following the event.
- This event reinforces Amgen’s role as a leading biotechnology company recognized in 2024 for innovation and employer excellence by Fast Company and Forbes.
19 Articles
19 Articles
Albuquerque Journal
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., May 30, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:20 a.m. ET on Wednesday, June 4, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Murdo Gordon,…
CytoSorbents to Participate at the Jefferies Global Healthcare Conference
PRINCETON, N.J., May 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one…
The Victoria Advocate
Kilgore News HeraldARTHEx Biotech to Participate in the 2025 Jefferies Global Healthcare Conference
VALENCIA, Spain, May 29, 2025 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 2025 Jefferies Global Healthcare Conference, being held June 3-5,…
Missoulian
Kyverna Therapeutics to Present at the Jefferies Global Healthcare Conference
EMERYVILLE, Calif., May 28, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at…
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time. A live audio webcast of the presentation will be available on the Investor Relations section of the Company’s website at https://ir.bruker.com. A r…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
